Ultra-Low-Dose Interleukin-2 in Unresectable Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ultra-Low-Dose Interleukin-2 in Unresectable Hepatocellular Carcinoma

Published:2002-06 Issue:3 Volume:25 Page:224-226
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Palmieri Giovannella,Montella Liliana,Milo Mario,Fiore Rosaria,Biondi Edoardo,Bianco Angelo Raffaele,Martignetti Angelo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference8 articles.

1. Adoptive immunotherapy with lymphokine-activated killer cells plus recombinant interleukin 2 in patients with unresectable hepatocellular carcinoma

2. Adjuvant adoptive immunotherapy against hepatocellular carcinoma

3. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

4. Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma

5. Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma;Cells;2021-07-27

2. In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma;Frontiers in Immunology;2021-05-07

3. Molecular Targets in Hepatocarcinogenesis and Implications for Therapy;Journal of Clinical Medicine;2018-08-13

4. Perspectives of immunotherapy in hepatocellular carcinoma (HCC);Zeitschrift für Gastroenterologie;2016-12-09

5. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers;Tumor Biology;2015-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3